The University of Chicago Header Logo

Connection

Daniel Shevrin to Benzamides

Back to Details
This is a "connection" page, showing publications Daniel Shevrin has written about Benzamides.
Daniel Shevrin
Connection Strength
0.047
Benzamides
  1. Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1549-1559.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.